US Stock MarketDetailed Quotes

Nektar Therapeutics (NKTR)

Watchlist
  • 70.620
  • -3.710-4.99%
Close May 15 15:59 ET
  • 70.228
  • -0.392-0.56%
Post 20:01 ET
2.39BMarket Cap-8.91P/E (TTM)

Nektar Therapeutics (NKTR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
9.69%-44.3M
-18.67%-208.51M
-40.64%-64.96M
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
Net income from continuing operations
11.75%-44.9M
-37.92%-164.08M
-596.89%-36.08M
4.14%-35.52M
20.57%-41.59M
-38.26%-50.88M
56.91%-118.96M
117.26%7.26M
19.15%-37.06M
-2.43%-52.36M
Operating gains losses
-60.77%1.75M
121.61%8.73M
--1.35M
--534K
--2.39M
--4.46M
-731.19%-40.39M
----
----
----
Depreciation and amortization
-64.55%151K
-76.63%1.03M
-42.77%190K
-80.26%196K
-85.33%214K
-73.49%426K
-43.81%4.39M
-79.90%332K
-41.42%993K
-32.64%1.46M
Deferred tax
----
----
----
----
----
----
----
----
-106.67%-31K
311.11%57K
Other non cash items
32.72%-4.58M
20.49%-28.75M
-97.83%-12.04M
43.95%-5.44M
39.10%-4.46M
47.78%-6.81M
17.05%-36.16M
45.64%-6.09M
20.77%-9.71M
-11.72%-7.32M
Change In working capital
53.42%-68K
-493.30%-37.02M
-101.03%-23.12M
-1,056.26%-10.17M
-132.97%-3.58M
97.81%-146K
68.71%-6.24M
-136.10%-11.5M
132.87%1.06M
216.03%10.86M
-Change in receivables
----
--0
--0
--0
--0
--0
-163.76%-3.05M
-320.62%-2.2M
2.19%-850K
45.84%2.42M
-Change in inventory
----
--0
--0
--0
--0
--0
-28.90%497K
21.85%1.31M
-94.80%123K
128.12%212K
-Change in payables and accrued expense
-81.74%1.39M
-147.83%-6.41M
-159.80%-7.52M
-165.06%-5.72M
-111.98%-799K
818.67%7.63M
166.51%13.4M
12.41%-2.89M
713.32%8.79M
162.67%6.67M
-Change in other current assets
115.93%949K
-268.98%-15.45M
-306.35%-9.86M
82.73%-618K
-64.73%985K
-510.45%-5.96M
-216.86%-4.19M
-179.82%-2.43M
-3.65%-3.58M
20.86%2.79M
-Change in other working capital
-32.87%-2.41M
-17.45%-15.16M
-8.80%-5.75M
-11.77%-3.83M
-204.28%-3.77M
38.71%-1.81M
-45.82%-12.91M
-90.66%-5.29M
-45.02%-3.42M
35.89%-1.24M
Cash from discontinued investing activities
Operating cash flow
9.69%-44.3M
-18.67%-208.51M
-40.64%-64.96M
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
Investing cash flow
Cash flow from continuing investing activities
-902.92%-350.79M
-100.84%-1.2M
-99.38%372K
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
Net PPE purchase and sale
-800.00%-18K
88.35%-171K
96.08%-18K
82.88%-114K
80.11%-37K
98.73%-2K
-486.32%-1.47M
-93.67%-459K
-154.95%-666K
-14.81%-186K
Net business purchase and sale
----
-101.07%-697K
----
----
----
----
--65.39M
----
----
----
Net investment purchase and sale
-890.24%-350.77M
-100.42%-329K
108.27%390K
-302.55%-94.76M
189.21%49.65M
128.63%44.39M
-43.49%78.65M
-126.75%-4.71M
-15.25%46.78M
-32.23%17.17M
Net other investing changes
----
----
----
--0
--0
---697K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-902.92%-350.79M
-100.84%-1.2M
-99.38%372K
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
Financing cash flow
Cash flow from continuing financing activities
7,564,885.71%529.55M
328.71%180.57M
46,491.57%38.67M
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
13K
5.56%19K
Net common stock issuance
--525.52M
6,128.33%180.85M
--38.26M
--142.59M
--0
--0
---3M
--0
--0
--0
Proceeds from stock option exercised by employees
57,828.57%4.06M
-97.12%866K
393.98%410K
1,730.77%238K
1,010.53%211K
-99.98%7K
100,293.33%30.12M
591.67%83K
--13K
5.56%19K
Net other financing activities
---25K
-107.67%-1.15M
--0
----
----
----
--15M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
7,564,885.71%529.55M
328.71%180.57M
46,491.57%38.67M
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
--13K
5.56%19K
Net cash flow
Beginning cash position
-65.84%15.12M
25.44%44.25M
36.28%41.03M
53.86%42.99M
-20.04%38.89M
25.44%44.25M
-60.02%35.28M
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
Current changes in cash
2,610.02%134.46M
-424.56%-29.14M
-283.67%-25.92M
-189.08%-1.96M
119.75%4.09M
-140.06%-5.36M
116.94%8.98M
147.59%14.11M
-84.63%2.2M
21.39%-20.7M
Effect of exchange rate changes
--0
250.00%6K
--0
103.57%1K
700.00%6K
87.50%-1K
-106.45%-4K
312.50%33K
71.43%-28K
-100.93%-1K
End cash Position
284.58%149.58M
-65.84%15.12M
-65.84%15.12M
36.28%41.03M
53.86%42.99M
-20.04%38.89M
25.44%44.25M
25.44%44.25M
-53.62%30.11M
-44.92%27.94M
Free cash flow
9.66%-44.32M
-17.78%-208.68M
-39.30%-64.98M
-9.59%-48.88M
-20.82%-45.78M
-2.10%-49.06M
8.42%-177.18M
1.35%-46.65M
-5.80%-44.6M
26.69%-37.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 9.69%-44.3M-18.67%-208.51M-40.64%-64.96M-10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M
Net income from continuing operations 11.75%-44.9M-37.92%-164.08M-596.89%-36.08M4.14%-35.52M20.57%-41.59M-38.26%-50.88M56.91%-118.96M117.26%7.26M19.15%-37.06M-2.43%-52.36M
Operating gains losses -60.77%1.75M121.61%8.73M--1.35M--534K--2.39M--4.46M-731.19%-40.39M------------
Depreciation and amortization -64.55%151K-76.63%1.03M-42.77%190K-80.26%196K-85.33%214K-73.49%426K-43.81%4.39M-79.90%332K-41.42%993K-32.64%1.46M
Deferred tax ---------------------------------106.67%-31K311.11%57K
Other non cash items 32.72%-4.58M20.49%-28.75M-97.83%-12.04M43.95%-5.44M39.10%-4.46M47.78%-6.81M17.05%-36.16M45.64%-6.09M20.77%-9.71M-11.72%-7.32M
Change In working capital 53.42%-68K-493.30%-37.02M-101.03%-23.12M-1,056.26%-10.17M-132.97%-3.58M97.81%-146K68.71%-6.24M-136.10%-11.5M132.87%1.06M216.03%10.86M
-Change in receivables ------0--0--0--0--0-163.76%-3.05M-320.62%-2.2M2.19%-850K45.84%2.42M
-Change in inventory ------0--0--0--0--0-28.90%497K21.85%1.31M-94.80%123K128.12%212K
-Change in payables and accrued expense -81.74%1.39M-147.83%-6.41M-159.80%-7.52M-165.06%-5.72M-111.98%-799K818.67%7.63M166.51%13.4M12.41%-2.89M713.32%8.79M162.67%6.67M
-Change in other current assets 115.93%949K-268.98%-15.45M-306.35%-9.86M82.73%-618K-64.73%985K-510.45%-5.96M-216.86%-4.19M-179.82%-2.43M-3.65%-3.58M20.86%2.79M
-Change in other working capital -32.87%-2.41M-17.45%-15.16M-8.80%-5.75M-11.77%-3.83M-204.28%-3.77M38.71%-1.81M-45.82%-12.91M-90.66%-5.29M-45.02%-3.42M35.89%-1.24M
Cash from discontinued investing activities
Operating cash flow 9.69%-44.3M-18.67%-208.51M-40.64%-64.96M-10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M
Investing cash flow
Cash flow from continuing investing activities -902.92%-350.79M-100.84%-1.2M-99.38%372K-305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M
Net PPE purchase and sale -800.00%-18K88.35%-171K96.08%-18K82.88%-114K80.11%-37K98.73%-2K-486.32%-1.47M-93.67%-459K-154.95%-666K-14.81%-186K
Net business purchase and sale -----101.07%-697K------------------65.39M------------
Net investment purchase and sale -890.24%-350.77M-100.42%-329K108.27%390K-302.55%-94.76M189.21%49.65M128.63%44.39M-43.49%78.65M-126.75%-4.71M-15.25%46.78M-32.23%17.17M
Net other investing changes --------------0--0---697K----------------
Cash from discontinued investing activities
Investing cash flow -902.92%-350.79M-100.84%-1.2M-99.38%372K-305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M
Financing cash flow
Cash flow from continuing financing activities 7,564,885.71%529.55M328.71%180.57M46,491.57%38.67M1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K13K5.56%19K
Net common stock issuance --525.52M6,128.33%180.85M--38.26M--142.59M--0--0---3M--0--0--0
Proceeds from stock option exercised by employees 57,828.57%4.06M-97.12%866K393.98%410K1,730.77%238K1,010.53%211K-99.98%7K100,293.33%30.12M591.67%83K--13K5.56%19K
Net other financing activities ---25K-107.67%-1.15M--0--------------15M--0--0--0
Cash from discontinued financing activities
Financing cash flow 7,564,885.71%529.55M328.71%180.57M46,491.57%38.67M1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K--13K5.56%19K
Net cash flow
Beginning cash position -65.84%15.12M25.44%44.25M36.28%41.03M53.86%42.99M-20.04%38.89M25.44%44.25M-60.02%35.28M-53.62%30.11M-44.92%27.94M-36.79%48.64M
Current changes in cash 2,610.02%134.46M-424.56%-29.14M-283.67%-25.92M-189.08%-1.96M119.75%4.09M-140.06%-5.36M116.94%8.98M147.59%14.11M-84.63%2.2M21.39%-20.7M
Effect of exchange rate changes --0250.00%6K--0103.57%1K700.00%6K87.50%-1K-106.45%-4K312.50%33K71.43%-28K-100.93%-1K
End cash Position 284.58%149.58M-65.84%15.12M-65.84%15.12M36.28%41.03M53.86%42.99M-20.04%38.89M25.44%44.25M25.44%44.25M-53.62%30.11M-44.92%27.94M
Free cash flow 9.66%-44.32M-17.78%-208.68M-39.30%-64.98M-9.59%-48.88M-20.82%-45.78M-2.10%-49.06M8.42%-177.18M1.35%-46.65M-5.80%-44.6M26.69%-37.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More